14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of APVO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Aptevo Therapeutics Inc stock price on Wednesday moving between $0.680 and $0.749
(Updated on Apr 24, 2024)

Sell candidate since Apr 23, 2024 Loss -7.28% PDF

The Aptevo Therapeutics Inc stock price fell by -7.28% on the last day (Wednesday, 24th Apr 2024) from $0.736 to $0.683. During the last trading day the stock fluctuated 10.15% from a day low at $0.680 to a day high of $0.749. The price has fallen in 8 of the last 10 days and is down by -71.56% for this period. Volume has increased on the last day by 220 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 565 thousand shares were bought and sold for approximately $385.61 thousand.

Given the current short-term trend, the stock is expected to rise 56.58% during the next 3 months and, with a 90% probability hold a price between $1.07 and $12.79 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

APVO Signals & Forecast

There are few to no technical positive signals at the moment. The Aptevo Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.730 and $3.41. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, March 07, 2024, and so far it has fallen -89.66%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Aptevo Therapeutics Inc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Aptevo Therapeutics Inc stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0690 between high and low, or 10.15%. For the last week, the stock has had daily average volatility of 8.80%.

Aptevo Therapeutics Inc is oversold on RSI14 (10). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (APVO) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Aptevo Therapeutics Inc to open at $0.704, and during the day (based on 14 day Average True Range), to move between $0.246 and $1.12, which gives a possible trading interval of +/-$0.437 (+/-63.98%) up or down from last closing price. If Aptevo Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 127.96% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.768, some $0.0854 (12.51%) from the current price of $0.683, our system finds the risk reward not very attractive.

Is Aptevo Therapeutics Inc stock A Buy?

The Aptevo Therapeutics Inc stock holds several negative signals and despite the positive trend, we believe Aptevo Therapeutics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.748 Sell Candidate Unchanged

Predicted Opening Price for Aptevo Therapeutics Inc of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$0.704 ( 3.12%) $0.683

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for APVO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.773 13.22 %
R2 0.747 9.36 %
R1 0.730 6.98 %
Current price: 0.683
Support S1 0.678 -0.746 %
S2 0.661 -3.13 %
S3 0.635 -6.99 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.85 23.81 %
R2 0.783 14.71 %
R1 0.768 12.51 %
Current price 0.683
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Aptevo Therapeutics Inc Stock and on which exchange is it traded?
The symbol for Aptevo Therapeutics Inc is APVO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aptevo Therapeutics Inc Stock?
The Aptevo Therapeutics Inc stock holds several negative signals and despite the positive trend, we believe Aptevo Therapeutics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Aptevo Therapeutics Inc Stock?
Aptevo Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aptevo Therapeutics Inc Stock.

What's the current price of Aptevo Therapeutics Inc Stock?
As of the end of day on the Apr 24, 2024, the price of an Aptevo Therapeutics Inc (APVO) share was $0.683.

What is the 52-week high and low for Aptevo Therapeutics Inc Stock?
The 52-week high for Aptevo Therapeutics Inc Stock is $10.80 and the 52-week low is $0.125.

What is the market capitalization of Aptevo Therapeutics Inc Stock?
As of the Apr 24, 2024, the market capitalization of Aptevo Therapeutics Inc is 459.683K.

When is the next earnings date for Aptevo Therapeutics Inc?
The upcoming earnings date for Aptevo Therapeutics Inc is May 09, 2024.
Click to get the best stock tips daily for free!

About Aptevo Therapeutics Inc

Aptevo Therapeutics Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational ... APVO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT